Sensus Healthcare, Inc.

NasdaqCM:SRTS Stock Report

Market Cap: US$62.8m

Sensus Healthcare Future Growth

Future criteria checks 4/6

Sensus Healthcare is forecast to grow earnings and revenue by 82.8% and 13.1% per annum respectively while EPS is expected to grow by 81.9% per annum.

Key information

82.8%

Earnings growth rate

81.9%

EPS growth rate

Medical Equipment earnings growth16.5%
Revenue growth rate13.1%
Future return on equityn/a
Analyst coverage

Low

Last updated03 Apr 2024

Recent future growth updates

Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 11
Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Recent updates

Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk

Apr 16
Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk

Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 11
Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital

Oct 17
There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital

Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger

Jul 04
Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger

Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop

Mar 14
Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop

Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?

Mar 06
Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?

Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger

Oct 11
Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger

Sensus Healthcare Q2 GAAP EPS, revenue beats

Aug 04

Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month

May 21

Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts

May 11
Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts

Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist

Apr 29
Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist

Sensus Healthcare's (NASDAQ:SRTS) Earnings Are Of Questionable Quality

Apr 01
Sensus Healthcare's (NASDAQ:SRTS) Earnings Are Of Questionable Quality

Are Investors Undervaluing Sensus Healthcare, Inc. (NASDAQ:SRTS) By 31%?

Dec 17
Are Investors Undervaluing Sensus Healthcare, Inc. (NASDAQ:SRTS) By 31%?

We Discuss Why Sensus Healthcare, Inc.'s (NASDAQ:SRTS) CEO Compensation May Be Closely Reviewed

May 30
We Discuss Why Sensus Healthcare, Inc.'s (NASDAQ:SRTS) CEO Compensation May Be Closely Reviewed

Sensus Healthcare: Likely Post-Pandemic Sales Recovery Can Boost Share Price

Apr 26

Analysts Expect Breakeven For Sensus Healthcare, Inc. (NASDAQ:SRTS) Before Long

Apr 19
Analysts Expect Breakeven For Sensus Healthcare, Inc. (NASDAQ:SRTS) Before Long

Sensus Healthcare's (NASDAQ:SRTS) Stock Price Has Reduced 30% In The Past Three Years

Feb 23
Sensus Healthcare's (NASDAQ:SRTS) Stock Price Has Reduced 30% In The Past Three Years

Earnings and Revenue Growth Forecasts

NasdaqCM:SRTS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025323N/AN/A1
12/31/2024261N/AN/A2
12/31/2023240-2-2N/A
9/30/202325-1-15-15N/A
6/30/2023302-12-12N/A
3/31/2023386-11-10N/A
12/31/20224524-2-1N/A
9/30/2022442777N/A
6/30/2022412544N/A
3/31/2022342144N/A
12/31/202127400N/A
9/30/202119011N/A
6/30/202115-2-3-3N/A
3/31/202111-4-2-2N/A
12/31/202010-7-10N/A
9/30/202013-700N/A
6/30/202017-611N/A
3/31/202024-355N/A
12/31/201927-2-3-2N/A
9/30/201927-3-5-4N/A
6/30/201927-2-5-5N/A
3/31/201926-3-13-12N/A
12/31/201826-2-9-9N/A
9/30/201825-3-7-6N/A
6/30/201823-3-5-5N/A
3/31/201822-3-4-4N/A
12/31/201721-4-3-3N/A
9/30/201719-3N/A-2N/A
6/30/201718-2N/A-3N/A
3/31/201716-2N/A-3N/A
12/31/2016150N/A-1N/A
9/30/2016140N/A-2N/A
6/30/2016130N/A-1N/A
3/31/2016110N/A-1N/A
12/31/201510-1N/A-1N/A
9/30/20158-2N/A-1N/A
12/31/20146-4N/A-2N/A
12/31/2013100N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SRTS's forecast earnings growth (82.8% per year) is above the savings rate (2.4%).

Earnings vs Market: SRTS's earnings (82.8% per year) are forecast to grow faster than the US market (14.5% per year).

High Growth Earnings: SRTS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: SRTS's revenue (13.1% per year) is forecast to grow faster than the US market (8.3% per year).

High Growth Revenue: SRTS's revenue (13.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SRTS's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.